No patients died of prostate cancer. The 5-year overall survival was 90%.

At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...

Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy techniques, an expert said. For patients with low- to intermediate-risk ...

Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study. Administration of radiotherapy in conjunction with hormone treatment has ...

Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized ...

New guidelines on stereotactic body radiotherapy for primary renal cell carcinoma address optimal dosing, the role of biopsy, follow-up practices, and the treatment of patients with a solitary kidney.

The addition of a short-course of ADT to metastasis-directed therapy delays progression in patients with oligometastatic hormone-sensitive prostate cancer. Adding 6 months of androgen deprivation ...

Please provide your email address to receive an email when new articles are posted on . Five-fraction SBRT appeared noninferior to conventional radiotherapy. Grade 2 or higher gastrointestinal adverse ...

A new study suggests individualized MRI surveillance of the spine based on patients' risk for progression after spine stereotactic body radiotherapy (SBRT) can optimize the detection of disease ...

Stereotactic body radiotherapy (SBRT) is a safe treatment option for patients with oligometastatic cancer, with only 0.5% of patients experiencing severe acute toxicities within 6 months, according to ...

Among 874 patients, those randomized to CRT had a biochemical/clinical failure-free rate of 94.6% versus 95.8% for those randomized to SBRT (HR 0.73, 90% CI 0.47-1.12, P=0.004), reported Nicholas van ...

Please provide your email address to receive an email when new articles are posted on . Patients with central lung tumors treated with single-fraction radiation did not experience any grade 3 or ...